Log in to search using one of your social media accounts:

 

Two weeks to bowel cancer?

There’s no doubt antibiotics have saved a lot of lives. But because they’ve been overprescribed for so many years we’ve ended up with a slew of health problems. For one thing, overuse of antibiotics wreaks havoc on your microbiome… That’s your body’s ecosystem. Your microbiome has 100 trillion or so bacteria, viruses and fungi. It affects just about every organ and body system. Some of these gut bugs cause disease and infection. But other good bacteria are called “probiotics.” They boost your immune system. They help you digest your food and turn it into vitamins. But in your gut, antibiotics kill off good bacteria along with the bad. When that happens, your immune system gets weak. Your risk of obesity and heart disease goes up. So do rates of allergies, asthma, autism and autoimmune diseases.1 And now shocking new research says antibiotics can even spike your risk of bowel cancer. And it can happen in just two weeks! A study in the journal Gut looked at data from 16,000 women over 60 years old. They were part of the famous Nurses Health Study.2  Results showed that taking antibiotics increased their risk of getting adenomas or polyps. These are growths on the lining of the bowel that can become cancerous. Women who took antibiotics in their 20s and 30s for as little as 15 days to two months increased their risk by up to 36%. It was worse for those who took these drugs in their 40s and 50s for longer periods of time....
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Cancer Health Men's Health Source Type: news

Related Links:

CONCLUSION: The results demonstrate ethnic, race, age and gender disparities in iCCA incidence and survival, and confirm continued increase in iCCA incidence in the United States. PMID: 29469047 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
CONCLUSIONS: The PNPLA3 gene is associated with NAFLD in Mexican population. More studies are required to explain the high prevalence of PNPLA3 polymorphism in Mexican-Americans, Mexican-Indians, and Mexican-Mestizos. PMID: 29469042 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
Purpose: To analyze the effects of a dexamethasone intravitreal implant (DEX; Ozurdex 700 μg; Allergan) administered immediately after cataract surgery in diabetic patients. Methods: This prospective, single-arm, open label study (NCT01748487 at ClinicalTrials.gov) involved Type 2 diabetic patients with at least mild diabetic retinopathy (DR) who underwent cataract surgery and DEX insertion after phacoemulsification, and intraocular lens implantation were enrolled. Best-corrected visual acuity and central retinal thickness (CRT) measured by spectral-domain optical coherence tomography were recorded at 1 week preope...
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
Privately held IDx is developing an artificial intelligence-based system that could help with the diagnosis diabetic retinopathy – a disease that leads to blindness if undetected. The company met its endpoints in a pivotal trial of the IDx-DR system. The trial involved 900 diabetes patients at 10 sites. The study was designed to evaluate the diagnostic accuracy of the technology in detecting moderate to severe diabetic retinopathy, including macular edema. The results of the pivotal trial met the study hypotheses that were developed in consultation with FDA and demonstrated the IDx-DR system exceeded these performanc...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Medical Device Business Source Type: news
Enzalutamide may have a role in prostate cancer therapy, but randomized trials are needed, says Dr Chodak.Medscape Urology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Urology Commentary Source Type: news
February 23, 2018—(BRONX, NY)—Earlier this week, in a crowded conference room in the Price Center/Block Pavilion, members of the Einstein-Montefiore community hosted a special visit from U.S. Congressman Joseph Crowley (D-NY, 14th District). At his office’s request, Rep. Crowley met with more than a dozen BOLD Buddies, volunteer peer mentors who provide support for cancer patients and survivors in the Bronx. Members of the group shared their personal stories and explained commitment to offer their support, hope and encouragement to others facing cancer and treatment at all stages of disease.
Source: Einstein News - Category: Universities & Medical Training Source Type: news
Sodium glucose co‐transporter 2 (SGLT2) inhibitors and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are antihyperglycaemic agents with weight‐lowering effects. The efficacy and safety of the SGLT2 inhibitor canagliflozin as add‐on therapy in Japanese patients with type 2 diabetes mellitus (T2DM) and inadequate glycaemic control with a GLP‐1RA (≥12 weeks) were evaluated in this phase IV study. Patients received canagliflozin 100 mg once daily for 52 weeks. Efficacy endpoints included the change in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), bodyweight, systolic blood pressure (SBP), ...
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Tags: BRIEF REPORT Source Type: research
CONCLUSIONSAAT was well tolerated and safe in subjects with new‐onset type 1 diabetes. Weekly doses of AAT greater than 90 mg/kg may be necessary for an optimal therapeutic effect.
Source: Pediatric Diabetes - Category: Endocrinology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Objective: Severity of illness scores rest on the assumption that patients have normal physiologic values at baseline and that patients with similar severity of illness scores have the same degree of deviation from their usual state. Prior studies have reported differences in baseline physiology, including laboratory markers, between obese and normal weight individuals, but these differences have not been analyzed in the ICU. We compared deviation from baseline of pertinent ICU laboratory test results between obese and normal weight patients, adjusted for the severity of illness. Design: Retrospective cohort study in ...
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Clinical Investigations Source Type: research
More News: Allergy | Allergy & Immunology | Artichokes | Asparagus | Asthma | Autism | Autoimmune Disease | Bananas | Bowel Cancer | Cancer | Cancer & Oncology | Cardiology | Chemistry | Children | Colorectal Cancer | Eating Disorders & Weight Management | Environmental Health | Fruit | Garlic | Gastrointestinal Polyps | Heart | Heart Disease | Heart Transplant | Leeks | Lung Transplant | Meat | Milk | Nurses | Nursing | Obesity | Onions | Peas | Polyps | Probiotics | Prostate Cancer | Study | Sugar | Sweeteners | Toxicology | Vegetables | Vitamins | Women